Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi-Aventis China Funds Clinical Practice Guideline Program For Hypertension

This article was originally published in PharmAsia News

Executive Summary

China recently kicked off a clinician practice guideline initiative, which will be adopted by the Chinese Medical Association. Hosted by the China International Medical Foundation and funded by Sanofi-Aventis China, one program will establish an expert panel to study the use of Irbesartan to control hypertension. To help physicians solve common clinical problems and raise the success rate of hypertension control, international and domestic academic exchanges will be held for Chinese cardiovascular-related experts. Meanwhile, China will conduct a survey on hypertension drug applications across the country. (Click here for more - Chinese Language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071145

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel